$BSX Recent Headlines Boston Scientific bulks up in China

New Post Public Reply Private Reply Replies (0) Message Board

Dec 27, 2013 at 9:51 AM

$BSX Recent Headlines

Boston Scientific bulks up in China 2:45 a.m. Dec. 24, 2013 - MarketWatch.com
These S&P winners have room to grow in 2014 6:00 a.m. Dec. 23, 2013 - Jeff Reeves
Facebook up on S&P inclusion; Hilton jumps on debut 4:19 p.m. Dec. 12, 2013 - Sue Chang
Best Buy falls 11% on warning; Tesla fires in focus 4:25 p.m. Nov. 19, 2013 - Sue Chang
Boston Scientific up on device OK; Medtronic stumbles on earnings 11:09 a.m. Nov. 19, 2013 - Russ Britt
A red flag against following billionaires’ trades 10:09 a.m. Nov. 15, 2013 - The Trading Deck
Top performers’ top November bets 11:01 p.m. Nov. 3, 2013 - Mark Hulbert
Apple gains on Icahn letter, Muddy Waters hits NQ 3:26 p.m. Oct. 24, 2013 - Sue Chang
Boston Scientific loss narrows; adjusts guidance 6:49 a.m. Oct. 24, 2013 - MarketWatch.com
Ford, Microsoft, Amazon are stocks to watch 4:00 a.m. Oct. 24, 2013 - Sue Chang
What IBM’s revenue miss really means 9:51 a.m. Oct. 17, 2013 - Mark Hulbert
Bullish technicals vie with debt-ceiling deadline 11:38 a.m. Oct. 15, 2013 - Michael Ashbaugh
Bullish technicals vie with debt-ceiling deadline 11:22 a.m. Oct. 15, 2013 - Michael Ashbaugh
Device firms, Regeneron see gains while general markets fear shutdown 12:36 p.m. Sept. 30, 2013 - Russ Britt
One possible reason why device tax passed in the first place — soaring margins 1:32 p.m. Sept. 26, 2013 - Russ Britt
Investors don't see hope for repeal of Obamacare medical-device tax 10:36 a.m. Sept. 26, 2013 - Russ Britt
Dow industrials reclaim the 50-day average 10:55 a.m. Sept. 12, 2013 - Michael Ashbaugh
Groupon climbs to 14-month high close on upgrade 3:28 p.m. Sept. 5, 2013 - Sue Chang
Tuesday’s movers: Facebook takes a breather 3:41 p.m. Aug. 27, 2013 - Sue Chang
Thursday’s movers: Facebook has its best day ever 3:55 p.m. July 25, 2013 - Sue Chang

Boston Scientific Inc. (BSX): Today's Featured Health Care Winner 5:00 p.m. Dec. 23, 2013 - TheStreet.com
St. Jude Medical Hits New 52-Week High - Analyst Blog 2:40 p.m. Dec. 23, 2013 - Zacks.com
Boston Scientific Plans China Expansion, Seeks Acquisitions 10:39 a.m. Dec. 23, 2013 - WSJ.com
Boston Scientific Upped to Buy - Analyst Blog 4:00 p.m. Dec. 20, 2013 - Zacks.com
NEOG Lags on Q2 Earnings, Revs Beat - Analyst Blog 2:21 p.m. Dec. 20, 2013 - Zacks.com
Omeros Corp. (OMER) Jumps: Stock Rises 18.1% - Tale of the Tape 9:11 a.m. Dec. 19, 2013 - Zacks.com
Boston Scientific Corporation (BSX) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape 8:19 a.m. Dec. 19, 2013 - Zacks.com
BSX'S Cardiac Implants Obtain CE Mark - Analyst Blog 6:35 p.m. Dec. 18, 2013 - Zacks.com
Boston Scientific Inc. Stock Downgraded (BSX) 10:11 a.m. Dec. 17, 2013 - TheStreet.com
Boston Scientific Receives CE Mark Approval for X4 Quadripolar CRT-D Systems 7:05 a.m. Dec. 17, 2013 - benzinga.com
BSX WATCHMAN OK'd by FDA Panel - Analyst Blog 6:45 p.m. Dec. 12, 2013 - Zacks.com
Why Boston Scientific (BSX) Jumped Today 5:40 p.m. Dec. 12, 2013 - TheStreet.com
Boston Scientific’s Watchman wins FDA panel’s backing, shares +3.7% 8:30 a.m. Dec. 12, 2013 - Seeking Alpha
UPDATE: FDA Advisory Panel Votes 13-1 on Benefits of Boston Scientific WATCHMAN Left Atrial Appendage Closure Device 8:03 p.m. Dec. 11, 2013 - benzinga.com
Boston Scientific Inc. (BSX): Today's Featured Health Services Laggard 5:01 p.m. Dec. 10, 2013 - TheStreet.com
Stryker's Momentum Continues to Build 1:00 p.m. Dec. 10, 2013 - RealMoney.com
Canaccord backs bullish outlook for Vascular Solutions 8:37 a.m. Dec. 10, 2013 - Seeking Alpha
5 Stocks Underperforming Today In The Health Services Industry 12:04 p.m. Dec. 9, 2013 - TheStreet.com
Boston Scientific CFO's $6.9 Million Sale 11:56 a.m. Dec. 9, 2013 - Barrons.com
Edwards Lifesciences Sees Weak Valve Sales 11:04 a.m. Dec. 9, 2013 - WSJ.com

Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio 8:00 a.m. Dec. 25, 2013 - PR Newswire
Boston Scientific Announces CE Mark Approval And First Implants Of Its Next-Generation X4 Quadripolar CRT-D Systems 8:01 a.m. Dec. 17, 2013 - PR Newswire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
Boston Scientific Elects David Roux To Its Board of Directors 8:30 a.m. Dec. 16, 2013 - PR Newswire
FDA Advisory Panel Votes Favorably on the Boston Scientific WATCHMAN(TM) Left Atrial Appendage Closure Device 7:49 p.m. Dec. 11, 2013 - PR Newswire
Updated Financial Standings, Company Announcements, and Upcoming Investors Conferences - Research Report on Zimmer, Boston Scientific, Hospira, Elan, and Incyte 8:00 a.m. Dec. 10, 2013 - PR Newswire
Vascular Solutions Granted Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter 6:02 p.m. Dec. 9, 2013 - GlobeNewswire
Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra(TM) Spinal Cord Stimulator System 9:00 a.m. Dec. 6, 2013 - PR Newswire
Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER(TM) Stent System 7:00 a.m. Dec. 6, 2013 - PR Newswire
FDA Approval, FY 2013 & Q4 FY 2013 Outlook, and Stock Price Updates - Research Report on Bio-Reference Laboratories, Zimmer, Boston Scientific, Covance, and MAKO Surgical 8:00 a.m. Dec. 2, 2013 - PR Newswire
Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System 9:00 a.m. Nov. 25, 2013 - PR Newswire
Upcoming Webinars, FDA Clearances, Preclinical Data Presentations, Completed Acquisitions and Financial Results - Research Report on Teva, Boston Scientific, Alnylam, Wright Medical, and Onconova 8:00 a.m. Nov. 25, 2013 - PR Newswire
Global Earth Energy, Inc.'s (GLER) Partner Hawk Manufacturing Provides Forecast 1:00 p.m. Nov. 22, 2013 - GlobeNewswire
Boston Scientific To Participate In 25th Annual Piper Jaffray Healthcare Conference 9:06 a.m. Nov. 22, 2013 - PR Newswire
Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific 5:01 p.m. Nov. 21, 2013 - PR Newswire
Boston Scientific Receives FDA Clearance And CE Mark Approval For Direxion(TM) Torqueable Microcatheter 6:02 p.m. Nov. 19, 2013 - PR Newswire
EBS Technologies Appoints Karl Schweitzer, JD, MBA, Medtronic's Former Vice President and General Manager of Neuromodulation, as a Director 9:50 a.m. Nov. 19, 2013 - BusinessWire
BioLife Solutions Appoints Raymond W. Cohen as Chairman and Joe Schick to Board of Directors 6:00 a.m. Nov. 19, 2013 - PR Newswire
Boston Scientific Vercise(TM) Deep Brain Stimulation System Receives CE Mark Approval for Treatment of Dystonia 4:00 a.m. Nov. 19, 2013 - PR Newswire
Boston Scientific Announces First Commercial Implants Of The Lotus(TM) Valve System in Europe 10:54 a.m. Nov. 15, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...